ALC - ALCON INC


77.82
-2.480   -3.187%

Share volume: 2,077,113
Last Updated: 04-21-2026
Medical Equipment/Ophthalmic Goods: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$80.30
-2.48
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
0.94%
1 Month
8.31%
3 Months
-1.62%
6 Months
5.99%
1 Year
-12.13%
2 Year
-13.94%
Key data
Stock price
$77.82
P/E Ratio 
N/A
DAY RANGE
$77.36 - $80.28
EPS 
N/A
52 WEEK RANGE
$71.55 - $99.20
52 WEEK CHANGE
-$13.94
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-19-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,266,504
AVERAGE 30 VOLUME 
$1,326,873
Company detail
CEO: David J. Endicott
Region: US
Website: alcon.com
Employees: 25,200
IPO year: 2019
Issue type:
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products. Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables. Vision Care segment provides daily disposable, reusable, reusable and color-enhancing contact lenses.

Recent news